Below are some of the key investment decisions that our portfolio managers have made and the reasons for them.

IPO

Nutritional Growth Solutions IPO

Nutritional Growth Solutions (NGS) has opened its Initial Public Offer (IPO) for investment, enabling you to invest in the company through Baker Young...
Buy

APX: An intelligent buy

APX’s long-term growth opportunity is supported by increasing Artificial Intelligence data requirements from its major customers. The company is profitable
Buy

COH: Listen up, opportunity knocks

An excellent opportunity to add to your existing position, in what is a world-leading hearing aid (Cochlear implants) developer, at very attractive...
Buy

TYR: An attractive Tech opportunity

We see the current pull back as an opportunity to gain exposure to a technology leader, with an established growing market, at very attractive levels...
IMP

IMP Monthly Report | August 2020

August was another strong month, as global markets continued their remarkable recovery from the March lows amidst ongoing optimism regarding reopening...
Advisor profile

Taking five with Alex Martin

The interesting takeaway for me has been the shift from traditional market favourites, such as big banks, Telstra and oil stocks, to emerging companies...
IPO

Pan Asia Metals IPO

Pan Asia Metals has hit the ASX IPO market, with Baker Young as Joint Lead Manager, to raise $6M...
Advisor profile

Taking five with Michael Zollo

"My clients get an edge when it comes to dealing in micro cap and small cap ASX listed companies..."
company update

Company update: Alexium International

Whilst many businesses have been adversely affected due to the COVID-19 lockdown, Alexium International, from all reports is returning to more normal...
Buy

Codan Limited – local hero

BUY - Codan Limited (ASX:CDA) has a pristine balance sheet with $85M in net cash and trades on respectable 21x 12 month earnings forecasts...
IMP

IMP Monthly Report | July 2020

The Australian share market finished 0.5% higher in July, however, momentum was lost as spiking COVID-19 cases began to weigh on confidence...
IPO

Helping kids reach new heights

IPO OPPORTUNITY - Baker Young recently completed the $1.5M pre-IPO for Nutritional Growth Solutions. NGS is now moving towards a considered IPO...
Corporate

SUDA Pharmaceuticals rights issue

Currently trading at 3 cents, SUDA Pharmaceuticals is a small cap biopharmaceutical company which is focused on the reformulation of established drugs...
Corporate

Baker Young Corporate Advisory success

Last month Baker Young Corporate Advisory achieved of a significant milestone, the completion of over A$55m in raised capital...